Optimising Adoptive T Cell Therapy Following Allogeneic Hematopoietic Stem Cell Transplantation
(2010)
Book Chapter
Ghorashian, S., Wright, G., Thomas, S., Hart, D. P., King, J., Voisine, C., …Stuass, H. J. (2010). Optimising Adoptive T Cell Therapy Following Allogeneic Hematopoietic Stem Cell Transplantation. In Y. Reisner, & M. F. Martelli (Eds.), Bone Marrow Transplantation Across Major Genetic Barriers (373-395). United Kingdom: World Scientific. https://doi.org/10.1142/9789814271271_0016
Allogeneic hematopoietic stem cell transplantation (HSCT) is carried out to correct genetic disorders of the hematopoietic system, as well as to treat hematopoietic malignancies. Adoptive Tcell therapy has great potential as an adjunct to this treatm... Read More about Optimising Adoptive T Cell Therapy Following Allogeneic Hematopoietic Stem Cell Transplantation.